Cover Image

Distribution of virulence factors, antimicrobial resistance genes and phylogenetic relatedness among Shiga toxin-producing Escherichia coli serogroup O91 from human infections

Shiga toxin-producing Escherichia coli (STEC) belonging to the serogroup O91 are among the most common non-O157 STEC serogroups associated with human illness in Europe. This study aimed to analyse the virulence factors, antimicrobial resistance genes and phylogenetic relatedness among 48 clinical ST...

Full description

Saved in:

Bibliographic Details
Main Authors:	Magdalena Nüesch-Inderbinen (Author), Marc J.A. Stevens (Author), Nicole Cernela (Author), Andrea Müller (Author), Michael Biggel (Author), Roger Stephan (Author)
Format:	Book
Published:	Elsevier, 2021-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative phenotypic characterization of hybrid Shiga toxin-producing / uropathogenic Escherichia coli, canonical uropathogenic and Shiga toxin-producing Escherichia coli
by: Noble Selasi Gati, et al.
Published: (2021)

Epidemiology of Shiga toxin producing <it>Escherichia coli </it>in Australia, 2000-2010
by: Vally Hassan, et al.
Published: (2012)

Genomic analysis of Shiga toxin-producing escherichia coli from patients and food handlers
by: H. Baba, et al.
Published: (2020)

Shiga toxin-producing Escherichia coli in human, cattle and foods. Strategies for detection and control
by: Nora Lia Padola
Published: (2014)

Application of Bacteriophages on Shiga Toxin-Producing <i>Escherichia coli</i> (STEC) Biofilm
by: Nicola Mangieri, et al.
Published: (2021)

Virulence markers, phylogenetic evolution, and molecular techniques of uropathogenic Escherichia coli
by: Etefia U Etefia, et al.
Published: (2020)

Escherichia coli strains producing a novel Shiga toxin 2 subtype circulate in China
by: Xi Yang, et al.
Published: (2020)

Virulence, phylogenetic background and antimicrobial resistance in Escherichia coli associated with extraintestinal infections
by: Katarína Čurová, et al.
Published: (2020)

Diminazene aceturate: an antibacterial agent for Shiga-toxin-producing Escherichia coli O157:H7
by: Wu SY, et al.
Published: (2016)

Anti-tumor activity of Escherichia coli Shiga toxin A subunit delivered by SF9 insect cells
by: Mana Oloomi, et al.
Published: (2018)

Prevalence of Shiga Toxin-Producing Escherichia coli in diarrheal patients in Faisalabad region of Pakistan as determined by multiplex PCR
by: Mashkoor Mohsin,1 Arshad Hussain,2 Muhammad Asghar Butt,2 Saira Bashir,1 Ayesha Tariq,1 Shoaib Babar,2 Aamir Ali,1 Asma Haque,1 Yasra Sarwar,1 and Abdul Haque1
Published: (2007)

Whole genome sequencing to characterize shiga toxin-producing Escherichia coli O26 in a public health setting
by: Baha Abdalhamid, et al.
Published: (2019)

Virulence property, phylogenetic background, and resistance pattern of Escherichia coli isolates from wound infections
by: Arindam Chakraborty, et al.
Published: (2017)

OMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves
by: Matias Fingermann, et al.
Published: (2018)

Prevalence and molecular characterization of Shiga toxin-producing Escherichia coli isolates from human and sheep in Al-Madinah Al-Munawarah
by: Eman Fathi Sharaf, et al.

Diarrheagenic <i>E. coli</i> in hospitalized patients: Special reference to Shiga-like toxin producing <i> <i>Escherichia</i> coli</i>
by: Lanjewar Mrudul, et al.
Published: (2010)

Characterization of a Lytic Bacteriophage as an Antimicrobial Agent for Biocontrol of Shiga Toxin-Producing <i>Escherichia coli</i> O145 Strains
by: Yen-Te Liao, et al.
Published: (2019)

Steroid Pulse Therapy for Severe Central Nervous System Involvement in Shiga Toxin-Producing Escherichia coli-Related Hemolytic Uremic Syndrome
by: Chiara Rosazza, et al.
Published: (2021)

Antimicrobial Resistance of Non-O157 Shiga Toxin-Producing <i>Escherichia coli</i> Isolated from Humans and Domestic Animals
by: Yanyu Pan, et al.
Published: (2021)

DNA fingerprinting of Shiga-toxin producing <it>Escherichia coli </it>O157 based on Multiple-Locus Variable-Number Tandem-Repeats Analysis (MLVA)
by: Vardund Traute, et al.
Published: (2003)

Activity of Bacteriophage and Complex Tannins against Biofilm-Forming Shiga Toxin-Producing <i>Escherichia coli</i> from Canada and South Africa
by: Emmanuel W. Bumunang, et al.
Published: (2020)

Phylogenetic Diversity, Antibiotic Resistance, and Virulence of <i>Escherichia coli</i> Strains from Urinary Tract Infections in Algeria
by: Anfal Kara, et al.
Published: (2024)

Differences of virulence factors, and antimicrobial susceptibility according to phylogenetic group in uropathogenic Escherichia coli strains isolated from Korean patients
by: Miri Hyun, et al.
Published: (2021)

Facilitators and barriers to implementing successful exclusion among children with shiga toxin-producing Escherichia coli: a qualitative analysis of public health case management records
by: Amoolya Vusirikala, et al.
Published: (2024)

Synergistic Effects of Bacteriophage vB_Eco4-M7 and Selected Antibiotics on the Biofilm Formed by Shiga Toxin-Producing <i>Escherichia coli</i>
by: Agnieszka Necel, et al.
Published: (2022)

Virulence factor profiles, phylogenetic background, and antimicrobial resistance pattern of lactose fermenting and nonlactose fermenting Escherichia coli from extraintestinal sources
by: Arindam Chakraborty, et al.
Published: (2016)

Development of a real-time PCR assay and comparison to CHROMagarTM STEC to screen for Shiga toxin-producing Escherichia coli in stool, Cape Town, South Africa
by: John B. Kalule, et al.
Published: (2017)

Peripheral nervous system manifestations of Shiga toxin-producing E. coli-induced haemolytic uremic syndrome in children
by: Luisa Santangelo, et al.
Published: (2021)

Down-Regulation of Renal Klotho Expression by Shiga Toxin 2
by: Martina Feger, et al.
Published: (2014)

Treatment of Shiga-Toxin Hus with Severe Neurologic Features with Eculizumab
by: Jacob H. Umscheid, et al.
Published: (2021)

Chemokine Expression in Human Astrocytes in Response to Shiga Toxin 2
by: Naomi Kioka, et al.
Published: (2012)

Tracing the Evolutionary Pathways of Serogroup O78 Avian Pathogenic <i>Escherichia coli</i>
by: Eun-Jin Ha, et al.
Published: (2023)

Molecular Detection of Antibiotic Resistance Genes in Shiga Toxin-Producing <i>E. coli</i> Isolated from Different Sources
by: Momna Rubab, et al.
Published: (2021)

Inhibition of Shiga toxin-converting bacteriophage development by novel antioxidant compounds
by: Sylwia Bloch, et al.
Published: (2018)

Atypical Presentation of Shiga Toxin Haemolytic Uremic Syndrome (STEC-HUS)
by: Inês Marques, et al.
Published: (2022)

Molecular characterization and phylogenetic relatedness of dog-derived Rabies Viruses circulating in Cameroon between 2010 and 2016.
by: Serge Alain Sadeuh-Mba, et al.
Published: (2017)

Decrease in Shiga toxin expression using a minimal inhibitory concentration of rifampicin followed by bactericidal gentamicin treatment enhances survival of <it>Escherichia coli </it>O157:H7-infected BALB/c mice
by: Abdelnoor Alexander M, et al.
Published: (2011)

Development of an enterotoxigenic Escherichia coli vaccine based on the heat-stable toxin
by: Ephrem Debebe Zegeye, et al.
Published: (2019)

Study of virulence factors of uropathogenic Escherichia coli and its antibiotic susceptibility pattern
by: Seema Mittal, et al.
Published: (2014)

<i>Escherichia coli</i> Phylogenetic and Antimicrobial Pattern as an Indicator of Anthropogenic Impact on Threatened Freshwater Mussels
by: Simone Varandas, et al.
Published: (2023)